The science and understanding underpinning the Covid-19 outbreak is emerging at an unprecedented and impressive rate around the world. Led by a team based at icddr,b in Dhaka, Bangladesh, the aim is to drive and seek wider engagement with teams across the region to illustrate and promote the studies and research strategies, planned and underway as part of this global effort to respond. These initiatives seek to strengthen research capacity, promote and recognise locally-led health research, improve visibility of research teams and centres, and contribute to the science of sharing.
...................................
Here we attempt to bring together all the information, resources and updates being provided by all the Asian networks and pan-Asian organisations who work in health research. The aim is to make it as easy as possible to find the right information, support and guidance, by connecting all the Asian initiatives together and making all the sources of reliable information and tools both accessible and discoverable.
The first cases of COVID-19 in Asia were reported to the WHO on 31st December 2019, via the WHO China Country Office. The cases, detected in Wuhan City, Hubei Province, were the first cases of COVID-19 to be reported globally and as the cause of the condition was then unknown they were reported as 'cases of pneumonia with unknown etiology (unknown cause)'. The causative agent was identified as a novel coronavirus, later named SARS-CoV-2, on 7th Jan 2020 by the Chinese authorities.
As of the 3rd of December 2020 Asia has 9.8 million cases and 161,000 deaths. The response to COVID-19 of individual countries in Asia varies hugely. Each individual country's coronavirus status can be accessed here, a website updated daily with the cases and deaths of each country in Asia. All countries in Asia except Turkmenistan and North Korea have reported COVID-19 cases.
The Impact of COVID-19 on Contraceptive Commodity Supply: Global Implications from a Supply Chain Analysis of India
Date: Tuesday, December 15, 2020
Time: 5:00 pm GMT Time (London), 7:00 pm West Africa Summer Time, 11:00 pm Central Asia Time
Join Abt Associates for a webinar to learn how the COVID-19 pandemic has impacted global contraceptive supply.
The presentation will discuss findings from a COVID-19 market assessment of the Indian contraceptive supply chain and its implications for global supply chains, will explain how disruptions to the Indian market have affected global exports, and will share key policy recommendations for public and private stakeholders to help mitigate the negative impacts of the pandemic on contraceptive supply and access.
The discussants will reflect on how the pandemic has affected supply- and demand-side factors and how they have adapted global procurement processes, in-country distribution, and organizational operations in the face of COVID-19 disruptions.
Statement by WHO Regional Director Dr Ahmed Al-Mandhari on COVID-19
Asia Resources - per Country
Click your country to see links to resources
If you have anything to add or suggestions on what would be useful please get in touch info@theglobalhealthnetwork.org
Key research organisation contacts:
The following is a list of contacts within Asian organisations, including the WHO Regional Groups, China CDC and other institutions who are preparing to deal with this response. You can find more information also via the partner links listed in the right hand navigation.